Abstract Potent arpromidine-type histamine H 2 receptor agonists such as BU-E-76 (He 90481) were among the first non-peptides reported to display weak neuropeptide Y (NPY) Y 1 receptor antagonist activity. In search of new chemical leads for the development of more